Microsatellite instability and sensitivity to FOLFOX treatment in metastatic colorectal cancer (vol 27, pg 2715, 2007)

被引:0
|
作者
Guetz, G. D. [1 ]
机构
[1] Kyungpook Natl Univ, Dept Biol, Taegu 702701, South Korea
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:3667 / 3667
页数:1
相关论文
共 50 条
  • [21] Prognostic value of microsatellite instability in adjuvant treatment of colorectal cancer
    Potapov, Oleksii A.
    Glagolieva, Anastasia Y.
    Makhmudov, Dmytro E.
    Komorowski, Andrzej L.
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2018, 72 : 540 - 546
  • [22] Comment on: "Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry"
    Yu, Chaoran
    TARGETED ONCOLOGY, 2019, 14 (03) : 365 - 366
  • [23] Comment on: “Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry”
    Chaoran Yu
    Targeted Oncology, 2019, 14 : 365 - 366
  • [24] Impact of BRAF Mutation and Microsatellite Instability on the Pattern of Metastatic Spread and Prognosis in Metastatic Colorectal Cancer
    Tran, Ben
    Kopetz, Scott
    Tie, Jeanne
    Gibbs, Peter
    Jiang, Zhi-Qin
    Lieu, Christopher H.
    Agarwal, Atin
    Maru, Dipen M.
    Sieber, Oliver
    Desai, Jayesh
    CANCER, 2011, 117 (20) : 4623 - 4632
  • [25] High incidence of microsatellite instability in colorectal cancer from African Americans (vol 9, pg 1112, 2003)
    Ashktorab, H
    Smoot, DT
    Carethers, JM
    Rahmanian, M
    Kittles, R
    Vosganian, G
    Doura, M
    Nidhiry, E
    Naab, T
    Momen, B
    Shekhani, S
    Giardiello, FM
    CLINICAL CANCER RESEARCH, 2003, 9 (08) : 3217 - 3217
  • [27] CHFR silencing and microsatellite instability as predictors of sensitivity to docetaxel and gemcitabine in colorectal cancer
    Pelosof, L.
    Yerram, S.
    Ahuja, N.
    Delmas, A.
    Danilova, L.
    Herman, J.
    Azad, N.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S33 - S33
  • [28] Motesanib with or without panitumumab plus FOLFIRI or FOLFOX for the treatment of metastatic colorectal cancer
    Niall Tebbutt
    Dusan Kotasek
    Howard A. Burris
    Lee S. Schwartzberg
    Herbert Hurwitz
    Joe Stephenson
    Douglas J. Warner
    Lisa Chen
    Cheng-Pang Hsu
    David Goldstein
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 993 - 1004
  • [29] Microsatellite instability status in metastatic colorectal cancer and effect of immune checkpoint inhibitors on survival in MSI-high metastatic colorectal cancer
    Okamoto, W.
    Nakamura, Y.
    Shiozawa, M.
    Komatsu, Y.
    Denda, T.
    Hara, H.
    Kagawa, Y.
    Narita, Y.
    Kawakami, H.
    Esaki, T.
    Nishina, T.
    Izawa, N.
    Ando, K.
    Moriwaki, T.
    Kato, T.
    Nagashima, F.
    Satoh, T.
    Nomura, S.
    Yoshino, T.
    Akagi, K.
    ANNALS OF ONCOLOGY, 2019, 30
  • [30] Motesanib with or without panitumumab plus FOLFIRI or FOLFOX for the treatment of metastatic colorectal cancer
    Tebbutt, Niall
    Kotasek, Dusan
    Burris, Howard A.
    Schwartzberg, Lee S.
    Hurwitz, Herbert
    Stephenson, Joe
    Warner, Douglas J.
    Chen, Lisa
    Hsu, Cheng-Pang
    Goldstein, David
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (05) : 993 - 1004